Indies Pharma Jamaica Limited (JMSE:INDIES)
Jamaica
· Delayed Price · Currency is JMD 3.370
-0.180 (-5.07%)
At close: Mar 12, 2025
Indies Pharma Jamaica Revenue
Indies Pharma Jamaica had revenue of 325.83M JMD in the quarter ending January 31, 2025, with 20.96% growth. This brings the company's revenue in the last twelve months to 1.22B, up 13.68% year-over-year. In the fiscal year ending October 31, 2024, Indies Pharma Jamaica had annual revenue of 1.16B with 9.81% growth.
Revenue (ttm)
1.22B
Revenue Growth
+13.68%
P/S Ratio
3.69
Revenue / Employee
18.70M
Employees
65
Market Cap
4.49B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sagicor Group Jamaica | 103.17B |
| Scotia Group Jamaica | 61.77B |
| NCB Financial Group | 123.93B |
| Barita Investments | 9.70B |
| Pan Jamaica Group | 43.18B |
| Wisynco Group | 56.15B |
| Caribbean Cement Company | 27.91B |
| GraceKennedy | 167.04B |